Moreover, inhibition of ROS-producing enzymes nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) expressed on CAFs can promote CD8+ T cell infiltration and enhance tumor response to ICB therapy [122]. This evidence concerns the gene CD8A and neoplasm.